Sanguine BioSciences Receives Seed Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=038155b8-55a6-43b5-9873-6800128706f5&Preview=1 - Date
2/22/2013 - Company Name
Sanguine BioSciences - Mailing Address
28903 Avenue Paine Valencia, CA 91355 - Company Description
Our mission is to facilitate and accelerate biomarker and personalized drug discovery by acknowledging the powerful role of the patient in research. We strive to develop meaningful relationships with patients that lead to empowerment and education. The Patient Portal will provide you information on how YOU can help accelerate research and treatments for your disease. - Website
http://www.sanguinebio.com - Transaction Type
Venture Equity - Transaction Amount
Undisclosed - Transaction Round
Seed - Proceeds Purposes
Sanguine plans to use the funds to scale its infrastructure to collect, process, document and store up to 1,000 blood samples a month on the West Coast. - M&A Terms
- Venture Investor
Invent Ventures - Venture Investor
Heliant Ventures
